/5
0 avis
Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial
Archive ouverte
Edité par CCSD ; American Society of Hematology -
International audience. no abstract
Consulter en ligne
Chargement des enrichissements...